《2009CCO/PET成像用于小細(xì)胞肺癌診斷》內(nèi)容簡(jiǎn)介:
What benefit to clinical management does positron emission tomography (PET) or positronemission tomography/computed tomography (PET/CT) contribute to the diagnosis orstaging of small cell lung cancer (SCLC).
《2009CCO/PET成像用于小細(xì)胞肺癌診斷》內(nèi)容預(yù)覽:
What benefit to clinical management does PET or PET/CT contribute to the assessment oftreatment response for small cell lung cancer.
What benefit to clinical management does PET or PET/CT contribute when recurrence ofsmall cell lung cancer is suspected but not proven.
What benefit to clinical management does PET or PET/CT contribute to restaging at thetime of documented recurrence for small cell lung cancer.
What is the role of PET when a solitary metastasis is identified at the time of recurrenceand the metastectomy is being contemplated.
點(diǎn)擊下載***:《2009CCO/PET成像用于小細(xì)胞肺癌診斷》
本共識(shí)意見(jiàn)(草案)依據(jù)我國(guó)胰腺囊性腫瘤的最近研究,并參考國(guó)際相關(guān)指南和研究...[詳細(xì)]
在美國(guó),結(jié)直腸癌發(fā)病率占所有癌癥的第四位,而死亡率為第二位。2012年估計(jì)...[詳細(xì)]
意見(jiàn)反饋 關(guān)于我們 隱私保護(hù) 版權(quán)聲明 友情鏈接 聯(lián)系我們
Copyright 2002-2024 Iiyi.Com All Rights Reserved